| 产品详情 |
| Edit |   |
|---|
| Product Name | Acalabrutinib |
|---|
| Description | Acalabrutinib, is an experimental anti-cancer drug and a selective Bruton's tyrosine kinase (BTK) inhibitor. This kinase transmits signals from B-cell Receptor (BCR), and thus any genetic BTK mutation causes B-Cell immunodeficiency. Therefore, BTK inhibitors targeting B-cell signaling has shown great promise for the treatment of chronic lymphocytic leukemia (CLL). Molecular Formula: C26H23N7O2 Molecular Weight: 465.51 |
|---|
| Size | 2.5mg, 5mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | n/a |
|---|
| Gene, Accession, CAS # | n/a |
|---|
| Catalog # | 440755 |
|---|
| Price | |
|---|
| Order / More Info | Acalabrutinib from UNITED STATES BIOLOGICAL |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|